BIVI BioVie Inc.

0.9098USD-3.50%Mkt Cap: 9.76M USDP/E: —

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that i…